Dr. Eswar Tipirneni
What this data tells you about Dr. Tipirneni
Dr. Eswar Tipirneni is a hematology & oncology specialist in San Antonio, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Tipirneni performed 24,345 Medicare services across 1,064 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tipirneni received a total of $646 from 8 pharmaceutical and/or device companies across 11 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tipirneni is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 15,400 | $0 | $2 |
| Anti-nausea injection (fosaprepitant) | 4,500 | $0 | $5 |
| Injection, granisetron hydrochloride, 100 mcg | 760 | $0 | $24 |
| Dexamethasone injection (steroid) | 660 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 480 | $1 | $114 |
| Complete blood count (CBC) with differential | 275 | $8 | $36 |
| Blood draw (venipuncture) | 257 | $8 | $20 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 227 | $22 | $157 |
| Comprehensive metabolic blood panel | 166 | $10 | $64 |
| Administration of chemotherapy into vein, 1 hour or less | 161 | $98 | $707 |
| Office visit, established patient (30-39 min) | 141 | $94 | $368 |
| Office visit, established patient (20-29 min) | 126 | $68 | $250 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 122 | $48 | $313 |
| Hospital follow-up visit, high complexity | 112 | $90 | $357 |
| Drug injection, under skin or into muscle | 109 | $11 | $96 |
| Ferritin level test (iron stores) | 87 | $13 | $60 |
| Iron level test | 87 | $6 | $27 |
| Iron binding capacity test | 87 | $9 | $35 |
| Measurement of immunoglobulin light chains | 72 | $17 | $60 |
| Office visit, established patient, complex (40-54 min) | 60 | $126 | $496 |
| Administration of chemotherapy into vein, each additional hour | 51 | $21 | $161 |
| Injection, diphenhydramine hcl, up to 50 mg | 51 | $1 | $7 |
| Lactate dehydrogenase (enzyme) level | 46 | $6 | $31 |
| Unclassified drugs | 44 | $1 | $8 |
| Administration of additional new drug or substance into vein, 1 hour or less | 43 | $49 | $344 |
| New patient office visit, complex (60-74 min) | 36 | $157 | $709 |
| Infusion, normal saline solution , 1000 cc | 34 | $2 | $19 |
| Vitamin B-12 level test | 32 | $15 | $76 |
| Folic acid level test | 28 | $14 | $73 |
| Infusion into a vein for hydration, each additional hour | 26 | $10 | $75 |
| Initial hospital admission, moderate complexity | 25 | $100 | $470 |
| New patient office visit (45-59 min) | 23 | $110 | $565 |
| Initial hospital admission, high complexity | 17 | $128 | $694 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (54%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Tipirneni is a mixed practice specialist, with moderate Medicare volume, with speaking/promotional industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Tipirneni experienced with iron sucrose injection (venofer)?
Does Dr. Tipirneni receive payments from pharmaceutical companies?
How do Dr. Tipirneni's costs compare to other hematology & oncology specialists in San Antonio?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology